Anti-nausea effects and pharmacokinetics of ondansetron, maropitant and metoclopramide in a low-dose cisplatin model of nausea and vomiting in the dog: a blinded crossover study

Kenward, H; Elliott, J; Lee, T; Pelligand, L

Abstract

Nausea is a subjective sensation which is difficult to measure in non-verbal species. The aims of this study were to determine the efficacy of three classes of antiemetic drugs in a novel low dose cisplatin model of nausea and vomiting and measure change in potential nausea biomarkers arginine vasopressin (AVP) and cortisol. A four period cross-over blinded study was conducted in eight healthy beagle dogs of both genders. Dogs were administered 18 mg/m2 cisplatin intravenously, followed 45 min later by a 15 min infusion of either placebo (saline) or antiemetic treatment with ondansetron (0.5 mg/kg; 5-HT3 antagonist), maropitant (1 mg/kg; NK1 antagonist) or metoclopramide (0.5 mg/kg; D2 antagonist). The number of vomits and nausea associated behaviours, scored on a visual analogue scale, were recorded every 15 min for 8 h following cisplatin administration. Plasma samples were collected to measure AVP, cortisol and antiemetic drug concentrations.

Citation

Kenward, H., Elliott, J., Lee, T., & Pelligand, L. (2017). Anti-nausea effects and pharmacokinetics of ondansetron, maropitant and metoclopramide in a low-dose cisplatin model of nausea and vomiting in the dog: a blinded crossover study. BMC Veterinary Research, 13(1), 244. https://doi.org/10.1186/s12917-017-1156-7

• Journal Article Type: Article
• Acceptance Date: Aug 3, 2017
• Publication Date: Aug 16, 2017
• Deposit Date: Aug 22, 2017
• Publicly Available Date: Aug 22, 2017
• Journal: BMC Veterinary Research
• Electronic ISSN: 1746-6148
• Publisher: BioMed Central
• Peer Reviewed: Peer Reviewed
• Volume: 13
• Issue: 1
• Pages: 244
• DOI: https://doi.org/10.1186/s12917-017-1156-7
• Public URL: https://rvc-repository.worktribe.com/output/1390803